January 28, 2025 -
Toronto, CANADA – January 28th, 2025 – MolecuLight Corp., a leader in point-of-care fluorescence imaging for wound care, is excited to announce that Dr. Michael N. Desvigne, a renowned board-certified plastic surgeon and wound care clinician, will present the clinical and surgical benefits of MolecuLight’s fluorescence imaging
… Read More
January 9, 2025 -Strategic financing will enable MolecuLight to further accelerate commercialization
Pittsburgh, PA January 6, 2025 – MolecuLight Inc.., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load in wounds, today announced it has secured a $27.5 million investment from Hayfin Capital Management LLP (“Hayfin”).
… Read More
May 30, 2024 -
Toronto, CANADA – May 30th, 2024 – MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, celebrates the publication of a groundbreaking study in the prestigious Burns Journal. Titled “Bacterial Fluorescence Imaging as a Predictor
… Read More
May 2, 2024 -Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care
Toronto, CANADA and London, UK – (May 1, 2024) – MolecuLight Corp., the leader in point-of-care digital wound measurement and real-time bacterial detection through fluorescence imaging, announces that its MolecuLight wound imaging
… Read More 
